Nordhealth AS (OSL:NORDH)
Norway
· Delayed Price · Currency is NOK 27.00
-1.80 (-6.25%)
At close: Mar 9, 2026
Nordhealth AS Revenue
In the year 2025, Nordhealth AS had annual revenue of 50.84M EUR with 11.31% growth. Nordhealth AS had revenue of 12.57M in the quarter ending December 31, 2025, with 3.86% growth.
Revenue
50.84M EUR
Revenue Growth
+11.31%
P/S Ratio
3.60
Revenue / Employee
112.98K EUR
Employees
450
Market Cap
2.17B NOK
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 699.77M |
| Photocure ASA | 532.58M |
| ArcticZymes Technologies ASA | 118.21M |
| Nykode Therapeutics AS | 4.57M |
| Vistin Pharma ASA | 452.29M |
| Omda AS | 495.69M |
| Lytix Biopharma AS | 377.00K |
| Circio Holding ASA | 123.00K |
Nordhealth AS News
- 4 months ago - Nordhealth AS (FRA:6E5) Q3 2025 Earnings Call Highlights: Revenue Growth and AI Investments ... - GuruFocus
- 4 months ago - Q3 2025 Nordhealth AS Earnings Call Transcript - GuruFocus